Glucotrack announces shareholder update

Rutherford, nj, nov. 13, 2023 (globe newswire) -- glucotrack, inc. (nasdaq: gctk) (“glucotrack” or the “company”), a medical device company focused on glucose monitoring technologies for people with diabetes and prediabetes, announced today that paul v. goode, phd, president and chief executive officer has provided a shareholder update letter.
GCTK Ratings Summary
GCTK Quant Ranking